Duke Lupus Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00512694|
Recruitment Status : Recruiting
First Posted : August 8, 2007
Last Update Posted : July 28, 2017
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women.
The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
|Condition or disease|
|Systemic Lupus Erythematosus Cutaneous Lupus|
The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the Duke Rheumatology clinic.
The Duke Lupus Registry has two main purposes:
- Improved patient care. By following disease activity scores and medication usage, we expect to improve our care of the patients seen in clinic.
- Future research on lupus outcomes. This may encompass a broad array of areas, including but not limited to cardiovascular health, pregnancy and fertility, infections, medication use, quality of life, and depression.
At each office visit, patients will complete a questionnaire, physicians will measure lupus activity, and patients may be asked to provide a small blood sample. Patients will not be required to make extra visits to Duke in order to participate -- all paperwork and blood draws will occur during a regularly scheduled office visit with the physician.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Duke Lupus Registry|
|Study Start Date :||July 2007|
|Estimated Primary Completion Date :||June 2019|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512694
|Contact: Laura Neil||(919) firstname.lastname@example.org|
|United States, North Carolina|
|Duke University Medical Center||Recruiting|
|Durham, North Carolina, United States, 27710|
|Contact: Martin Tochacek, PhD|
|Sub-Investigator: Lisa G. Criscione-Schreiber, MD|
|Principal Investigator: Megan E. B. Clowse, MD, MPH|
|Principal Investigator:||Megan E. B. Clowse, MD, MPH||Duke University|